Why did a 38-year-old woman with neurofibromatosis type 1 (NF1) develop choroidal Yasunari nodules in both eyes? That's what Danish clinicians had to figure out when the patient presented for a ...
The management of diabetic retinopathy requires an understanding of the importance of general medical management and when to consider laser therapies, intravitreal injection of medications, and ...
Diabetic macular edema treatment options include anti-vascular endothelial growth factor (anti-VEGF) injections and laser therapy, with patient-specific factors guiding the best approach. What are the ...
LAS VEGAS — Ranibizumab, a vascular endothelial growth-factor (VEGF) inhibitor that is part of the existing armamentarium for retina specialists, may be the first major treatment advance in 40 years ...
The goal of systemic management of risk factors (glucose, blood pressure and lipid control) is to prevent diabetic retinopathy (DR) incidence or progression to vision-threatening DR. The greatest ...
For prevention of diabetic retinopathy (DR) incidence or progression, the American Academy of Ophthalmology Preferred Practice Pattern (AAO PPP) and the American Diabetes Association Standards of Care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results